PART II - OTHER INFORMATION



Not applicable



Item 1.  Legal Proceedings



From time to time we are involved in litigation with respect to matters arising from the ordinary conduct of our business, and currently certain claims are pending against us. In the opinion of management, based upon presently available information, either adequate provision for anticipated costs have been accrued or the ultimate anticipated costs will not materially affect our consolidated financial position, results of operations, or cash flows.



Item 1A.  Risk Factors



There have been no significant changes to our risk factors since December 31, 2017.



Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds



On April 27, 2015, we announced that our Board of Directors authorized an expansion to its repurchase program by authorizing the purchase of an additional $25 million dollars of its common stock in the open market. This authorization has no expiration. As shown in the following table, there were no stock repurchases during the quarter ended March 31, 2018. 



[DATA_TABLE_REMOVED]



31

Item 6. Exhibits 



[DATA_TABLE_REMOVED]



